Surgical Precision: How Recombinant Human Thrombin Is Advancing...

ha aggiunto una foto Health

2026-07-14 13:29:56 - Translate -

Surgical Precision: How Recombinant Human Thrombin Is Advancing Surgical Bleeding Control

The Topical Recombinant Human Thrombin Market is experiencing significant growth as recombinant human thrombin continues to advance surgical bleeding control and hemostatic management. According to market reports, the global Topical Recombinant Human Thrombin Market was valued at USD 656.6 million in 2024 and is projected to reach USD 1,200 million by 2035, exhibiting a CAGR of 5.6%...

0 Commenti 0 condivisioni 215 Views 0 Anteprima